Sun Pharmaceuticals Is Said to Consider Acquiring Stada

Sun Pharmaceuticals Is Said to Consider Acquiring Stada

Kuni Takahashi/Bloomberg

Sun Pharmaceutical Industries Ltd., controlled by billionaire Dilip Shanghvi, has about $927 million of cash reserves and may seek acquisitions to broaden its geographic breadth or enhance its presence in the U.S., Nomura Holdings Inc. said in a May 31 report.